{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Wilmington",
      "state": "DE",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79290",
      "recalling_firm": "AstraZeneca Pharmaceuticals LP",
      "address_1": "1800 Concord Pike",
      "address_2": "N/A",
      "postal_code": "19897-0001",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0585-2018",
      "product_description": "Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmington, DE 19850   by: Patheon Pharmaceuticals, Inc. Cincinnati OH 45237  Product of Switzerland   NDC 0310-0657-58",
      "product_quantity": "18056 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L  (polymorph).",
      "recall_initiation_date": "20180223",
      "center_classification_date": "20180309",
      "termination_date": "20190226",
      "report_date": "20180314",
      "code_info": "HN0406  02/2018  JH0341   03/2018  JH0342   03/2018  JH0147   03/2018  JC0391   04/2018  JK0147   04/2018  JL0184   04/2018  JC0402  05/2018"
    }
  ]
}